Owl Peak Announces Addition of Barry Allen to their Board of Directors

Charlottesville, VA— 3/13/24

(Charlottesville, VA: DATE): Owl Peak Technologies, a life sciences company developing a novel screening solution for colorectal cancer, announced today that they have added veteran biotechnology CEO and investor Barry Allen to their Board of Directors. Mr. Allen is CEO of Sonic Incytes Medical Corp., a company focused on accessible and affordable healthtech solutions and is also an Associate at Creative Destruction Lab, a leading technology incubator.

Barry Allen is a serial founder and operator with 30 years of executive management and board experience in the medtech, software and digital industries in both public and private companies. Active in the startup community, Barry experience includes Founder, Chair and CEO of Zolo, President & CEO of Sonic Incytes, President & CEO of PureWeb Inc., Founder and CEO of VSM MedTech, Founder and CEO of Urodynamix, Chair of the BC Excels Program, Entrepreneur in Residence at Ventures West, and lead mentor with BC Innovation Council. Barry has held a number of directorships in private and public companies and is currently the Chair and Director of Zolo and Orpyx Medical.

“Barry’s depth of knowledge and expertise both developing and commercializing medical technologies including experience in endoscopic imaging and early cancer detection is an exciting value add to the Owl Peak pathway. We are thrilled to have him join our company as we solve for critical unmet needs,” said CEO Tim Harvey.

“I am thrilled to join Owl Peak at this critical time as we seek to move our technology to the next stage of development. This team and technology have incredible potential and we’ve only just begun to see what they can do,” said Mr. Allen.